🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Presented by Aditya Bardia, MD at #SABCS22 preliminary evidence on activity of neoadjuvant #TrastuzumabDeruxtecan with or without endocrine therapy in patients with #HER2low hormone receptor-positive #BreastCancer OncoAlert SABCS #bcsm

With Umberto Malapelle first Young Molecular Pathologist event 💥💥💥#trainingthenextgeneration ➡️ Proud of your great team of Oncologists, Molecular Biologists, Bioinfo & Pathologists!

.AACR President-Elect 2023-2024 Dr. Patricia M. LoRusso: “I always look at cancer as my enemy. It’s been my enemy for many, many years.” Her experiences led her to pursue a career focused on helping to develop new cancer treatments. bit.ly/3ZkKJvc

Se avete pazienti con tumore mammario HER2+ metastatici, segnalateceli pure. Finalmente lo studio alphabet è attivo anche in Italia! GEICAM - Cáncer de mama ETOP IBCSG Partners Foundation @BIGagainstBC #metastaticbreastcancer #pik3ca

The alarm clock didn’t work and you unfortunately missed our 6am USCAP symposium on HER2-low? Worry no more- the recording is now available on the PeerView website & YouTube! Lots of laughs & wonderful discussions with Stuart Schnitt and Jorge Reis Filho. lrn.peerview.com/150208223_1_we…

🔴È online il terzo episodio di "Sul tumore facciamo rumore", in cui affrontiamo il tema del tumore al polmone con Cristina Chiabotto e la Professoressa Caterina Marchiò Guarda il video > youtu.be/dRJpUU9LRWY

Esperienza unica Umberto Malapelle

Further evidence that identifying breast cancers that are truly and homogeneously “HER2 addicted” is a smart way to select patients for chemo-free anti-HER2 regimens #bcsm 👏Mothaffar Rimawi #rachelschiff @prat_aleix Matthew Goetz Carmine De Angelis and coauthors aacrjournals.org/clincancerres/…

Una spettacolare 35esima edizione del Salone Libro Torino! Grazie a tutti per aver partecipato e aver supportato la nostra @FPRConlus! Vuoi scoprire di più sull'evento "La Lettura...Che Cura!"? Clicca qui per leggere l'articolo de La Stampa > bit.ly/4361P2B

It was great! Bravo Matteo Lambertini, MD PhD

Most informative clinical study with TDXD in breast cancer so far

Filippo Montemurro Totally doable! 💪🏻

Led by Caterina Marchiò, our clinical pathway tool is designed to guide you through best practice for the detection & treatment of NTRK fusions in NSCLC, featuring the latest advances in targeted therapies, treatment recommendations & clinical trial data …c-biomarkers-ime.springermedicine.com/courses/detect…

Team work for the best testing for our patients! #ovariancancer #pathology #diagnosis #molecularpathology #precisionemdicine

Lovely talk from Caterina Marchiò on predictive biomarkers in breast cancer. She & colleagues are doing some very neat work in this area, including innovative studies sub-grouping HER2 low tumors to try to identify optimal responders. #USCAP2024

Brilliant short talks by @emadrakha, Caterina Marchiò, and Johns Hopkins Pathology Ashley Cimino-Mathews. What a treat to be there with this impressive crew! Our patients are in great hands.

Grateful to learn from a full house of Pathologists & talk about our work ECOG-ACRIN Cancer Research Group Johns Hopkins Kimmel Cancer Center JHBreastGynResearch Translational Breast Cancer Research Consortium! Thank you Anne Vincent-Salomon Hannah Wen for the invitation. Privileged to share the podium w/ the brilliant @emadrakha Caterina Marchiò & Dr Cimino-Mathews Johns Hopkins Pathology

This was a much needed piece of work! A must read for all experts working on diagnostic molecular profiling of solid tumors 🔬⏬️

Wonderful Evandro de Azambuja, MD, PhD ! Boss vs Leader…. it is not just a matter of wording 👏👏👏👏 👇👇👇👇👇 ESMO - Eur. Oncology Matteo Lambertini, MD PhD

Newly published ESMO recommendations provide roadmap for the implementation of molecular tumour boards in clinical practice. Discover the key focus areas to optimise #PrecisionOncology Read via #ESMODailyReporter: ow.ly/mexL50VvtUM Ben Westphalen Annals of Oncology